PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
30.36%
Revenue growth above 1.5x RUN's 12.90%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
101.11%
Positive gross profit growth while RUN is negative. John Neff would see a clear operational edge over the competitor.
665.55%
EBIT growth above 1.5x RUN's 23.91%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
665.55%
Operating income growth above 1.5x RUN's 0.47%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
2011.37%
Net income growth above 1.5x RUN's 460.66%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
1804.76%
EPS growth above 1.5x RUN's 456.14%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
2005.26%
Diluted EPS growth above 1.5x RUN's 436.85%. David Dodd would see if there's a robust moat protecting these shareholder gains.
4.77%
Share count expansion well above RUN's 1.22%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
3.70%
Diluted share count expanding well above RUN's 1.26%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
169.34%
Positive OCF growth while RUN is negative. John Neff would see this as a clear operational advantage vs. the competitor.
68.26%
FCF growth under 50% of RUN's 156.78%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-8.27%
Negative 10Y revenue/share CAGR while RUN stands at 231.43%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-8.27%
Negative 5Y CAGR while RUN stands at 64.82%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-8.27%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-93.35%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-93.35%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-93.35%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
123.37%
Below 50% of RUN's 1473.60%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
123.37%
Below 50% of RUN's 1185.12%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
123.37%
3Y net income/share CAGR 50-75% of RUN's 220.80%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.43%
AR growth well above RUN's 8.37%. Michael Burry fears inflated revenue or higher default risk in the near future.
24.59%
Inventory growth well above RUN's 18.52%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
63.80%
Asset growth above 1.5x RUN's 4.18%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
70.33%
BV/share growth above 1.5x RUN's 11.80%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
No Data
No Data available this quarter, please select a different quarter.
29.66%
We increase R&D while RUN cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
13.79%
We expand SG&A while RUN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.